Vesugen 20 mg

What is Vesugen?

Vesugen is the tripeptide lysyl-glutamyl-aspartate from the Khavinson bioregulator series, associated with vascular tissue research. Pepstral supplies it as a lyophilized powder for in-vitro laboratory research only.

→Read the full Vesugen research guide

What is Vesugen studied for?

• Vascular tissue research models
• Endothelial signalling assays
• Short-peptide bioregulator comparisons
• Ageing-model research

All applications above are in-vitro or preclinical research contexts. Vesugen is sold for laboratory research only and is not for human or animal use.

What does the certificate for lot VESU20-0528 show?

Every lot of Vesugen is tested by an independent US laboratory before it is listed. The report for lot VESU20-0528 is in the COA library and the lot number printed on the vial matches it. The current results:

How is Vesugen handled and stored?

Sealed vials are stored at -20°C away from light and keep for 24 months. To reconstitute, add bacteriostatic water slowly down the inside wall of the vial and swirl until clear; never shake. Once in solution, keep at 2 to 8°C and use within our 28-day default for a preserved solution. The concentration table gives the dilution volumes and microlitre aliquots for this vial.

Frequently asked questions

Related reading

• Pinealon vs epithalon: a tripeptide and a tetrapeptide from the same pineal programme, compared on sequence, certificate and literaturePinealon, Glu-Asp-Arg, 418.4, against epithalon, Ala-Glu-Asp-Gly, 390.3: sequences, certificates side by side, molar amounts.
• Vilon (Lys-Glu): a two-residue peptide, the certificate for lot VILON20-0528, and why a dipeptide is sold in 20 mg vialsVilon is the dipeptide Lys-Glu, mass 275.3. Lot VILON20-0528 reports six tests including sterility, 20 mg is 72.6 micromoles.
• What a peptide bioregulator is, and where the term came fromBioregulator is a category name, not a pharmacological class. Where the term came from, what it groups together, and what it does not establish.
• The Khavinson bioregulators: what the evidence actually saysThe bioregulators have a real literature, a coherent theory and thin independent replication. What the evidence supports, and where it stops.